Literature DB >> 7109669

Prognostic significance of the development of left bundle conduction defects following aortic valve replacement.

J L Thomas, R A Dickstein, F B Parker, J L Potts, R A Poirier, C T Fruehan, R H Eich.   

Abstract

The association of intraventricular conduction defects and aortic valvular disease is widely recognized. This study was undertaken to evaluate the effects on survival of left bundle conduction defects (LBCDs) as a consequence of aortic valve replacement. A total of 133 patients were followed between 1 and 70 months after operation, with a mean follow-up of 32.1 months. The incidence of intraoperative LBCDs was 31.6% or 42 patients. There were 13 deaths in the group of 42 patients with LBCDs compared to eight deaths in the group of 91 patients without such abnormalities (p less than 0.01). Sudden death occurred in five of 42 patients with postoperative LBCDs and two of 91 patients with normal intraventricular conduction (p less than 0.025). The survival rate in these patients with significant aortic stenosis and normal intraventricular conduction was 89.9%, whereas if LBCD had occurred after operation, the survival rate was 65.7% (p less than 0.005). If the LBCD was accompanied by a left axis deviation, the survival rate was 21.7%. Sudden death may be due either to a tachyarrhythmia or perhaps to progression from LBCD to complete heart block or trifascicular block. It is important that this group of patients be monitored closely after operation. There may be an indication to insert prophylactic permanent pacemakers in this group.

Entities:  

Mesh:

Year:  1982        PMID: 7109669

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  7 in total

1.  Comparison of multicenter registries and randomized control trials for transcatheter aortic valve replacement (TAVR).

Authors:  Shikhar Agarwal; E Murat Tuzcu; William Stewart; Navkaranbir Singh Bajaj; Lars G Svensson; Samir R Kapadia
Journal:  Indian Heart J       Date:  2013-07-10

Review 2.  Clinical significance of conduction disturbances after aortic valve intervention: current evidence.

Authors:  Manuel Martinez-Selles; Peter Bramlage; Martin Thoenes; Gerhard Schymik
Journal:  Clin Res Cardiol       Date:  2014-07-04       Impact factor: 5.460

3.  Incidence rate and predictors of permanent pacemaker implantation after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis.

Authors:  Valeria Calvi; Sergio Conti; Giusi Paola Pruiti; Davide Capodanno; Euglena Puzzangara; Donatella Tempio; Angelo Di Grazia; Gian Paolo Ussia; Corrado Tamburino
Journal:  J Interv Card Electrophysiol       Date:  2011-11-26       Impact factor: 1.900

Review 4.  New conduction abnormalities after TAVI--frequency and causes.

Authors:  Robert M van der Boon; Rutger-Jan Nuis; Nicolas M Van Mieghem; Luc Jordaens; Josep Rodés-Cabau; Ron T van Domburg; Patrick W Serruys; Robert H Anderson; Peter P T de Jaegere
Journal:  Nat Rev Cardiol       Date:  2012-05-01       Impact factor: 32.419

5.  Risk factors for pacemaker implantation following aortic valve replacement: a single centre experience.

Authors:  G Limongelli; V Ducceschi; A D'Andrea; A Renzulli; B Sarubbi; M De Feo; F Cerasuolo; R Calabrò; M Cotrufo
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

6.  Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium.

Authors:  Martin B Leon; Nicolo Piazza; Eugenia Nikolsky; Eugene H Blackstone; Donald E Cutlip; Arie Pieter Kappetein; Mitchell W Krucoff; Michael Mack; Roxana Mehran; Craig Miller; Marie-Angèle Morel; John Petersen; Jeffrey J Popma; Johanna J M Takkenberg; Alec Vahanian; Gerrit-Anne van Es; Pascal Vranckx; John G Webb; Stephan Windecker; Patrick W Serruys
Journal:  Eur Heart J       Date:  2011-01-06       Impact factor: 29.983

Review 7.  Conduction abnormalities after transcatheter aortic valve implantation.

Authors:  Panagiotis Karyofillis; Anna Kostopoulou; Sofia Thomopoulou; Martha Habibi; Efthimios Livanis; George Karavolias; Vassilis Voudris
Journal:  J Geriatr Cardiol       Date:  2018-01       Impact factor: 3.327

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.